Gottlieb Nomination Approved by Senate Panel

Dr. Scott Gottlieb testifies before a Senate Health Education Labor and Pension Committee confirmation hearing on his nomination to be commissioner of the Food and Drug Administration on Capitol Hill in Washington
Dr. Scott Gottlieb testifies before a Senate Health Education Labor and Pension Committee confirmation hearing on his nomination to be commissioner of the Food and Drug Administration on Capitol Hill in Washington

Earlier today, the Senate Health, Education, Labor, and Pensions Committee (HELP) voted favorably on the nomination of Dr. Scott Gottlieb as Commissioner of the Food & Drug Administration (FDA). Prior to the vote, pro-federal employee members of the committee sought to put Dr. Gottlieb on the record regarding important concerns of NTEU.

Five senators followed up on a letter they had sent earlier this year to Acting Commissioner Ostroff expressing concern about the impact of the Trump Administration’s hiring freeze on FDA’s ability to carry out its critical mission. Their new letter to the nominee (as the previous letter has not been responded to by the administration) reaffirmed the need that FDA have sufficient funding and personnel for both the duties funded by user fees and those by appropriations.

Separate from the letter, Senator Elizabeth Warren (D-MA) asked Dr. Gottlieb if he were confirmed as Commissioner, would he work cooperatively with employees and employee representatives, including unions, and would he meet with the NTEU national leadership soon after he began his duties.

The Gottlieb nomination will now go to the Senate floor.

I will keep you informed of further developments on this matter. If you have any immediate questions, please feel free to contact me or comment below.